Waldencast Investors

Waldencast Investors

Waldencast FY 2022 key highlights

$0M

FULL YEAR NET SALES

[0]

NET SALES GROWTH

$0M

FULL YEAR ADJ. EBITDA

$0M

ADJ. EBITDA GROWTH

OBAGI FY 2022 key highlights

$0M

FULL YEAR NET SALES

[0]

NET SALES GROWTH

$0M

FULL YEAR ADJ. EBITDA

$0M

ADJ. EBITDA GROWTH

MILK FY 2022 key highlights

$0M

FULL YEAR NET SALES

[0]

NET SALES GROWTH

$0M

FULL YEAR ADJ. EBITDA

$0M

ADJ. EBITDA GROWTH

Results & presentations

NASDAQ: +0.03 (1.86%)

WALD $1.64
stock information

EVENTS

Next

Participation in Upcoming event

All EVENTS

Press releases

Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand

Waldencast Reports Q1 2025 Financial Results

All press releases

contact investor relations